Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

NARCOMS Patient Registry

Register as a willing MS research participant to facilitate multicenter studies. Initiated by the Consortium of MS Centers.

Visit NARCOMS

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

Clinical Trial: UCSF MS and COVID-19 Immunity Study

MS treatment involves the use of medications that target the immune system, which can increase the risk of certain infections. This study is being conducted to get a better understanding of how immunity to COVID-19 vaccination may be impacted by MS treatments. Criteria fo...

Get Details
Clinical Trial: Immune responses to COVID vaccines in people with MS on ocrelizumab

It is not know whether people receiving ocrelizumab for MS mount adequate immune responses to COVID-19 vaccine. The study is designed to investigate B-cell and T-cell responses to COVID-19 vaccination in patients treated with Ocrevus. There are 5 visits for this study. All...

Get Details
Clinical Trial: autologous hematopoietic stem cell transplantation (AHSCT)

Investigators are recruiting 156 people with relapsing MS (relapsing-remitting MS or secondary progressive MS with relapses) at 19 sites nationwide for a pivotal clinical trial comparing autologous hematopoietic stem cell transplantation (AHSCT, also commonly known as HSCT) to...

Get Details
Clinical Trial: Ocrelizumab in Progressive MS (CONSONANCE)

The purpose of the study is to see if Ocrelizumab will halt the worsening of the signs and symptoms of Progressive forms of MS. Smartphone-based “passive monitoring” of participants will also take place during the study. It will collect data on gait and mobility throughout the...

Get Details
Clinical Trial: Ofatumumab for Patients with Relapsing Multiple Sclerosis

MS study evaluating the continued effectiveness, safety and tolerability of Ofatumumab in adults, between the ages 18-60, with relapsing multiple sclerosis who are transitioning from traditional anti-CD20 therapy. Click on this link to answer a few questions to see if you q...

Get Details
Clinical Trial: Ocrelizumab in Black Americans and Hispanic/Latinx with Relapsing MS

Investigators are recruiting 150 Black Americans and Hispanic/Latinx with relapsing MS to determine the effectiveness of Ocrevus ® (ocrelizumab) in these groups. The study, sponsored by Genentech, Inc., also is known as the CHIMES study. Read more

Get Details
Clinical Trial: ATOMIC Physical Activity Research Program for Teens with MS

Youth with MS are commonly physically inactive. Vigorous physical activity has shown to improve well-being while lowering MS disease activity in youth. There is currently a lack of useful physical activity tools developed for youth with MS. With the input of youth with MS, thi...

Get Details
Clinical Trial: Antioxidant for fatigue in MS

This clinical trial will evaluate the potential beneficial effects of Mitoquinone (MitoQ), an antioxidant, on MS fatigue. It will also explore the effects of MitoQ on cognitive function, quality of life and mood. Participants are adults between the ages of 18 and 70 diagnosed ...

Get Details
Clinical Trial: Ozanimod for Cognitive Function

This is a multicenter, single-arm, open-label study to describe the change from baseline in cognitive processing speed in subjects with relapsing multiple sclerosis (RMS) treated with ozanimod HCl 1 mg at 3 years. All enrolled subjects will receive orally administered ozanimod...

Get Details
Clinical Trial: Ozanimod to Improve Cognitive Function

Investigators are recruiting 250 people with relapsing forms of MS for a clinical trial to determine if ozanimod (Zeposia ® , Bristol Myers Squibb) improves cognitive functions, specifically information processing speed. The study is funded by Celgene. Read more

Get Details

|< < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 > >|

Learn About Clinical Trials

Participating in Clinical Trials

What you need to know about clinical trial participation.

Download the Guide

Discover More

Here are a few related topics that may interest you

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Newly Diagnosed

If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Participate in a Clinical Trial

Clinical Trials in MS

NARCOMS Patient Registry

Posting a Trial

Share

Clinical Trials In Your Area

Clinical Trial: UCSF MS and COVID-19 Immunity Study

Clinical Trial: Immune responses to COVID vaccines in people with MS on ocrelizumab

Clinical Trial: autologous hematopoietic stem cell transplantation (AHSCT)

Clinical Trial: Ocrelizumab in Progressive MS (CONSONANCE)

Clinical Trial: Ofatumumab for Patients with Relapsing Multiple Sclerosis

Clinical Trial: Ocrelizumab in Black Americans and Hispanic/Latinx with Relapsing MS

Clinical Trial: ATOMIC Physical Activity Research Program for Teens with MS

Clinical Trial: Antioxidant for fatigue in MS

Clinical Trial: Ozanimod for Cognitive Function

Clinical Trial: Ozanimod to Improve Cognitive Function

Share

Learn About Clinical Trials

Discover More

The National MS Society is Here to Help

We Are Here